kras mutation and glutathion The roles of in cancer metabolism, tumor microenvironment clinical therapy | Molecular Cancer Uncovering new therapeutic targets for
Uncovering new therapeutic targets for a common KRAS mutation behind cancer KRAS G12D: The Next Frontier in Cancer Therapy MedChemExpress Targeting KRAS mutant stomach colorectal tumors by disrupting the ERK2 p53 complex ScienceDirect KRAS OriGene Technologies Inc.
Pay in 4 interest-free payments of $6.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22



